Session date: 
03/12/2020 - 12:15pm to 1:15pm

Kejal Kantarci, M.D.

Learning Objectives:

  • Learn about the existing literature on the menopausal hormone therapy and risk of dementia
  • Discuss the timing hypothesis for the menopausal hormone therapy and dementia risk
  • Discuss the recent data from the menopausal hormone therapy trials that tested the timing hypothesis

Financial Disclosures - Grant/Research Support: Avid Radiopharmaceuticals
Off-label and/or Investigational Use Disclosure - None

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here. 

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010image within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. 

TRANSCRIPT
Any credit or attendance awarded from this series will appear on your Transcript.

Presenter: 
Kejal Kantarci, M.D.
Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota